John Armitage’s Labcorp LH Stock Holding History

John Armitage’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-978,953	Closed	-$151M	–	31
2018 Q2	$151M	Buy	+978,953	New	+$148M	1.15%	27

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

John Armitage's LH Position: Q3 2018 in Review

John Armitage sold out of Labcorp (LH) in Q3 2018, closing a stake of 978,953 shares — an estimated $151M sold.

John Armitage first reported a position in LH in Q2 2018 and held it in 1 quarter. The position peaked at $151M in Q2 2018. 794 funds tracked by Wall St. Rank hold LH as of Q3 2018.

John Armitage reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
John Armitage sold 978,953 Labcorp shares in Q3 2018, an estimated $151M.
John Armitage first reported a position in Labcorp in Q2 2018 and held it in 1 quarter.
John Armitage's Labcorp position peaked at $151M in Q2 2018.
794 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Egerton Capital (UK)'s 13F filing for Q3 2018, filed 13 Nov 2018.